Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1989-10-23
pubmed:abstractText
CM-H-9 monoclonal antibody specific for placental isoferritin (PLF) was used to quantify PLF in the serum and on peripheral blood lymphocytes derived from term delivery women and healthy controls. It was found that the mean level of PLF in maternal sera was 50.4 +/- 50.1 U/ml, whereas in normal adults the mean serum PLF level was very low (4.5 +/- 7.7 U/ml). Furthermore, term mothers exhibited a sub-population of peripheral blood lymphocytes (PBL) which stained positively with CM-H-9 MoAb (mean 11.6 +/- 7.8%). Such lymphocytes were scarce in normal non-pregnant women (mean 0.8 +/- 1.2%). The effect of PLF on lymphocyte transformation in MLC was studied in mixed lymphocyte cultures of maternal-newborn and normal non-related PBL controls. It was found that placental isoferritin was immunosuppressive in comparison to normal adult ferritin. The suppressive effect was significantly higher in maternal-newborn MLC compared to normal adult controls. Furthermore, it was found that PLF which is present in maternal serum has an immunosuppressive activity since, its removal on CM-H-9 MoAb affinity column abrogated this effect. The results of this study suggest that both PLF and PLF binding lymphocytes play a role in the development of immunosuppression during pregnancy. Therefore the lack of one of the factors may result in diminished immunosuppression or in fetal rejection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-1082352, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-1165108, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-116671, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-14144354, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-2496706, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-2581727, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-2943894, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-3498583, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-3665189, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-3817052, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-3871631, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-4106331, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-5389395, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-5462768, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-6239719, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-63986, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-6458580, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-65007, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-7228654, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-854054, http://linkedlifedata.com/resource/pubmed/commentcorrection/2528432-891036
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
257-62
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.
pubmed:affiliation
Neonatal Unit, Hasharon Hospital, Tel Aviv, Israel.
pubmed:publicationType
Journal Article